IP Library Granted Patent US 6,942,688
Granted Patent B2
US 6,942,688 · App. 09/782,444 · Granted Sep 13, 2005

Stent delivery system having delivery catheter member with a clear transition zone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,942,688
App. No.
09/782,444
Granted
Sep 13, 2005
Kind
B2
Abstract

A catheter based stent placement system in which the catheter has a clear or translucent transition zone for visual inspection of the stent when placed in the catheter.

Claims (10)

1. A medical device delivery system for a self-expanding stent comprising:

an outer sheath comprising an elongated tubular body and a distal section;

said sheath comprising an inner, polytetrafluoroethylene resin layer having stainless steel braiding disposed thereon, and a coating applied over and bonded to the braiding with the coating of said distal section formed from a light transmissive material;

an inner shaft located coaxially within said outer sheath, said shaft having a distal end and a proximal end;

a self-expanding stent located within said distal section of said outer sheath, said stent making frictional contact with said outer sheath, and said shaft connected to said stent for delivery of said stent;

said distal section being light transmissive whereby said stent may be visually inspected through said distal section, and further in which said distal section has a greater inside and outside diameter than the inside and outside diameter of said elongated, tubular body.

2. A medical device delivery system as defined in claim 1 , wherein said sheath includes a flexible distal tip bonded to the distal section, said distal tip comprising a polymeric formulation containing from about 20 to 75 weight percent of a polymeric radiopaque agent to be substantially more radiopaque than the distal section and the elongated tubular body member.

3. A medical device delivery system as defined in claim 2 , wherein said elongated tubular body member is comprised of a polymeric formulation containing less than about 20 weight percent of radiopaque agent to be substantially less radiopaque than the distal tip.

4. A medical device delivery system as defined in claim 2 , wherein said distal section is comprised of a clear nylon polymer.

5. A medical device delivery system as defined in claim 4 , wherein said elongated tubular body is comprised of a opaque nylon material.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →